Maintenance of hypertensive hemodynamics does not depend on ROS in established experimental chronic kidney disease

Diana A Papazova1, Arianne van Koppen1, Maarten P Koeners1

  • 1Department of Nephrology & Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.

Plos One
|February 18, 2014
PubMed

Insights

In chronic kidney disease (CKD), blood pressure and renal vascular resistance do not appear to depend on oxidative stress. This study found that reactive oxygen species are not key drivers of hypertension in established CKD.

Area of Science:

  • Nephrology
  • Cardiovascular Research
  • Oxidative Stress

Background:

  • Oxidative stress is prevalent in chronic kidney disease (CKD).
  • The link between oxidative stress and hypertensive renal hemodynamics in CKD is not fully understood.

Purpose of the Study:

  • To investigate if established CKD alters the dependence of blood pressure and renal vascular resistance on reactive oxygen species.
  • To determine the role of oxidative stress in the hemodynamics of established hypertensive CKD.

Main Methods:

  • CKD was induced in rats via bilateral kidney ablation.
  • Mean arterial pressure (MAP), renal vascular resistance (RVR), and glomerular filtration rate (GFR) were measured.
  • The effects of antioxidant (Tempol, PEG-catalase) or vehicle infusion on hemodynamics were assessed in CKD and control rats.

Main Results:

  • CKD rats exhibited proteinuria, decreased GFR, elevated MAP, RVR, and oxidative stress markers.
  • Antioxidants reduced MAP in controls but not significantly in CKD rats.
  • While antioxidants affected RVR and sodium excretion, they did not normalize hypertension in CKD, suggesting a reduced dependence on reactive oxygen species.

Conclusions:

  • Despite increased oxidative stress markers in CKD, mean arterial pressure and renal vascular resistance did not show a greater dependence on reactive oxygen species compared to controls.
  • Reactive oxygen species are unlikely to be direct determinants of hypertensive renal hemodynamics in this model of established CKD.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.9K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.6K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.4K